• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Rabeprazole Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5756232

MBS5756232 is an inhibitor targeting Rabeprazole. Rabeprazole is an inhibitor of H(+)-K(+)-exchanging atpase. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Rabeprazole, Inhibitor
Full Product Name
Rabeprazole
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
359.44
Solubility
DMSO: Soluble
(<1mg/ refers to the product slightly soluble or insoluble)
Formula
C18H21N3O3S
CAS Number
117976-89-3

Product References and Citations for Rabeprazole, inhibitor

Sue S, Ogushi M, Arima I, Kuwashima H, Nakao S, Naito M, Komatsu K, Kaneko H, Tamura T, Sasaki T, Kondo M, Shibata W, Maeda S. Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori: A multicenter, prospective, randomized trial. Helicobacter. 2017 Dec 21. doi: 10.1111/hel.12456. [Epub ahead of print] PubMed PMID: 29271026.
Rochoy M, Dubois S, Glantenet R, Gautier S, Lambert M. [Gastric acid rebound after a proton pump inhibitor: Narrative review of literature]. Therapie. 2017 Oct 26. pii: S0040-5957(17)30159-2. doi: 10.1016/j. Therap.2017.08.005. [Epub ahead of print] French. PubMed PMID: 29195714.
Toda R, Shiramoto M, Komai E, Yoshii K, Hirayama M, Kawabata Y. Pharmacokinetics and Pharmacodynamics of Azeloprazole Sodium, a Novel Proton Pump Inhibitor, in Healthy Japanese Volunteers. J Clin Pharmacol. 2017 Nov 28. doi: 10.1002/jcph.1038. [Epub ahead of print] PubMed PMID: 29193126.
Kinoshita Y, Kato M, Fujishiro M, Masuyama H, Nakata R, Abe H, Kumagai S, Fukushima Y, Okubo Y, Hojo S, Kusano M. Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study. J Gastroenterol. 2017 Nov 29. doi: 10.1007/s00535-017-1417-z. [Epub ahead of print] PubMed PMID: 29188387.

Other Notes

Small volumes of Rabeprazole, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000